MIS.F MONASH IVF GROUP LTD

Healthcare Biotechnology Frankfurt Exchange
0.4460 EUR
Close of Nov 12, 2026
0.3043 0.5250
Market cap
EUR 174M
P/E
44.6x
P/B
1.15x
ROE
3.0%
Dividend yield
3.20%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is MIS.F undervalued?

Graham number
Price0.4460
Graham value0.2948
Premium51.3%

MIS.F trades 51.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

MONASH IVF GROUP LTD fundamental analysis

No fundamental analysis for MONASH IVF GROUP LTD yet.

MONASH IVF GROUP LTD stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About MONASH IVF GROUP LTD

Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.

Full company profile